StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3023% below fair value
$4.64−0.21 (-4.33%)

Close on Nov 19, 2026Market cap $57.01MP/E –Yield –

Lensar operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Lensar's operating income for the twelve months ending Jun 30, 2026 was -$8.13M. For fiscal 2025 it was -$24.58M. The highest annual figure on record is -$10.67M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.58M–
FY2024Dec 31, 2024-$10.67M–
FY2023Dec 31, 2023-$12.23M–
FY2022Dec 31, 2022-$20.18M–
FY2021Dec 31, 2021-$19.65M–
FY2020Dec 31, 2020-$18.50M–
FY2019Dec 31, 2019-$12.71M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.13M–
Q1 FY2026Mar 31, 2026$2.24M–
Q4 FY2025Dec 31, 2025-$4.92M–
Q3 FY2025Sep 30, 2025-$7.58M–
Q2 FY2025Jun 30, 2025-$6.29M–
Q1 FY2025Mar 31, 2025-$5.79M–
Q4 FY2024Dec 31, 2024-$1.29M–
Q3 FY2024Sep 30, 2024-$1.25M–
Q2 FY2024Jun 30, 2024-$5.28M–
Q1 FY2024Mar 31, 2024-$2.85M–
Q4 FY2023Dec 31, 2023-$2.96M–
Q3 FY2023Sep 30, 2023-$2.04M–
Q2 FY2023Jun 30, 2023-$2.87M–
Q1 FY2023Mar 31, 2023-$4.36M–
Q4 FY2022Dec 31, 2022-$2.61M–
Q3 FY2022Sep 30, 2022-$4.08M–
Q2 FY2022Jun 30, 2022-$6.80M–
Q1 FY2022Mar 31, 2022-$6.68M–
Q4 FY2021Dec 31, 2021-$3.91M–
Q3 FY2021Sep 30, 2021-$6.17M–
Q2 FY2021Jun 30, 2021-$4.38M–
Q1 FY2021Mar 31, 2021-$5.20M–
Q4 FY2020Dec 31, 2020-$6.85M–
Q3 FY2020Sep 30, 2020-$4.71M–
Q2 FY2020Jun 30, 2020-$3.84M–
Q1 FY2020Mar 31, 2020-$3.10M–
Q4 FY2019Dec 31, 2019-$1.93M–
Q3 FY2019Sep 30, 2019-$5.34M–

More Lensar figures

See a number that looks wrong?